GlassScriptPhysician profile
Thomas R Conley
NPI 1811128077
$3,667.21
in general payments reported to CMS, 2019-2025
35 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $43.65 · 2021: $38.38 · 2022: $109 · 2023: $762 · 2024: $1,239 · 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,032.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,017.23 | 2022-2025 | Ubrelvy, Vraylar, Qulipta |
| Astrazeneca Pharmaceuticals LP | $477.71 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Pfizer INC. | $389.40 | 2019-2025 | |
| Glaxosmithkline, LLC. | $200.31 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $196.77 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $174.13 | 2019-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $146.40 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $144.85 | 2024-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $97.34 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.39 | 2019-2024 | Jardiance |
| Axsome Therapeutics, INC. | $58.20 | 2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $54.14 | 2019-2020 | |
| Astellas Pharma US INC | $52.91 | 2019-2024 | Veozah |
| Inspire Medical Systems, INC. | $50.13 | 2025 | Inspire |
| Dexcom, INC. | $48.28 | 2025 | Dexcom G6 Transmitter |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.